Skip to main content
Top
Published in: European Radiology 2/2022

01-02-2022 | Hepatocellular Carcinoma | Hepatobiliary-Pancreas

Gd-EOB-DTPA-enhanced MRI radiomics to predict vessels encapsulating tumor clusters (VETC) and patient prognosis in hepatocellular carcinoma

Authors: Yixing Yu, Yanfen Fan, Ximing Wang, Mo Zhu, Mengjie Hu, Cen Shi, Chunhong Hu

Published in: European Radiology | Issue 2/2022

Login to get access

Abstract

Objectives

The study was to develop a Gd-EOB-DTPA-enhanced MRI radiomics model for preoperative prediction of VETC and patient prognosis in hepatocellular cancer (HCC).

Methods

The study included 182 (training cohort: 128; validation cohort: 54) HCC patients who underwent preoperative Gd-EOB-DTPA-enhanced MRI. Volumes of interest including intratumoral and peritumoral regions were manually delineated in the hepatobiliary phase images, from which 1316 radiomics features were extracted. The least absolute shrinkage and selection operator (LASSO) and multivariable logistic regression were used to select the useful features. Clinical, intratumoral, peritumoral, combined radiomics, and clinical radiomics models were established using machine learning algorithms. The Kaplan–Meier survival analysis was used to assess early recurrence and progression-free survival (PFS) in the VETC + and VETC- patients.

Results

In the validation cohort, the area under the curves (AUCs) of radiomics models were higher than that of the clinical model using random forest (all p < 0.05). The peritumoral radiomics model (AUC = 0.972;95% confidence interval [CI]:0.887–0.998) had significantly higher AUC than intratumoral model (AUC = 0.919; 95% CI: 0.811–0.976) (p = 0.044). There were no significant differences in AUC between intratumoral or peritumoral radiomics model (PR) and combined radiomics model (p > 0.05). Early recurrence and PFS were significantly different between the PR-predicted VETC + and VETC- HCC patients (p < 0.05). PR-predicted VETC was independent predictor of early recurrence (hazard ratio [HR]: 2.08[1.31–3.28]; p = 0.002) and PFS (HR: 1.95[1.20–3.17]; p = 0.007).

Conclusions

The intratumoral or peritumoral radiomics model may be useful in predicting VETC and patient prognosis preoperatively. The peritumoral radiomics model may yield an incremental value over intratumoral model.

Key Points

• Radiomics models are useful for predicting vessels encapsulating tumor clusters (VETC) and patient prognosis preoperatively.
• Peritumoral radiomics model may yield an incremental value over intratumoral model in prediction of VETC.
• Peritumoral radiomics-model-predicted VETC was an independent predictor of early recurrence and progression-free survival.
Appendix
Available only for authorised users
Literature
1.
go back to reference Xu X, Zhang HL, Liu QP et al (2019) Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma. J Hepatol 70:1133–1144CrossRef Xu X, Zhang HL, Liu QP et al (2019) Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma. J Hepatol 70:1133–1144CrossRef
2.
go back to reference Huang X, Long L, Wei J et al (2019) Radiomics for diagnosis of dual-phenotype hepatocellular carcinoma using Gd-EOB-DTPA-enhanced MRI and patient prognosis. J Cancer Res Clin Oncol 145:2995–3003CrossRef Huang X, Long L, Wei J et al (2019) Radiomics for diagnosis of dual-phenotype hepatocellular carcinoma using Gd-EOB-DTPA-enhanced MRI and patient prognosis. J Cancer Res Clin Oncol 145:2995–3003CrossRef
3.
go back to reference Ma X, Wei J, Gu D et al (2019) Preoperative radiomics nomogram for microvascular invasion prediction in hepatocellular carcinoma using contrast-enhanced CT. Eur Radiol 29:3595–3605CrossRef Ma X, Wei J, Gu D et al (2019) Preoperative radiomics nomogram for microvascular invasion prediction in hepatocellular carcinoma using contrast-enhanced CT. Eur Radiol 29:3595–3605CrossRef
4.
go back to reference Renne SL, Woo HY, Allegra S et al (2020) Vessels encapsulating tumor clusters (VETC) is a powerful predictor of aggressive hepatocellular carcinoma. Hepatology 71:183–195CrossRef Renne SL, Woo HY, Allegra S et al (2020) Vessels encapsulating tumor clusters (VETC) is a powerful predictor of aggressive hepatocellular carcinoma. Hepatology 71:183–195CrossRef
5.
go back to reference Fang JH, Zhou HC, Zhang C et al (2015) A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an epithelial-mesenchymal transition-independent manner. Hepatology 62:452–465CrossRef Fang JH, Zhou HC, Zhang C et al (2015) A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an epithelial-mesenchymal transition-independent manner. Hepatology 62:452–465CrossRef
6.
go back to reference Fang JH, Xu L, Shang LR et al (2019) Vessels that encapsulate tumor clusters (VETC) pattern is a predictor of sorafenib benefit in patients with hepatocellular carcinoma. Hepatology 70:824–839CrossRef Fang JH, Xu L, Shang LR et al (2019) Vessels that encapsulate tumor clusters (VETC) pattern is a predictor of sorafenib benefit in patients with hepatocellular carcinoma. Hepatology 70:824–839CrossRef
7.
go back to reference Chen S, Feng S, Wei J et al (2019) Pretreatment prediction of immunoscore in hepatocellular cancer: a radiomics-based clinical model based on Gd-EOB-DTPA-enhanced MRI imaging. Eur Radiol 29:4177–4187CrossRef Chen S, Feng S, Wei J et al (2019) Pretreatment prediction of immunoscore in hepatocellular cancer: a radiomics-based clinical model based on Gd-EOB-DTPA-enhanced MRI imaging. Eur Radiol 29:4177–4187CrossRef
8.
go back to reference Chen Y, Qin X, Long L et al (2020) Diagnostic value of Gd-EOB-DTPA-enhanced MRI for the expression of Ki67 and microvascular density in hepatocellular carcinoma. J Magn Reson Imaging 51:1755–1763CrossRef Chen Y, Qin X, Long L et al (2020) Diagnostic value of Gd-EOB-DTPA-enhanced MRI for the expression of Ki67 and microvascular density in hepatocellular carcinoma. J Magn Reson Imaging 51:1755–1763CrossRef
9.
go back to reference Wu M, Tan H, Gao F et al (2019) Predicting the grade of hepatocellular carcinoma based on non-contrast-enhanced MRI radiomics signature. Eur Radiol 29:2802–2811CrossRef Wu M, Tan H, Gao F et al (2019) Predicting the grade of hepatocellular carcinoma based on non-contrast-enhanced MRI radiomics signature. Eur Radiol 29:2802–2811CrossRef
10.
go back to reference Lee S, Kim SH, Lee JE, Sinn DH, Park CK (2017) Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma. J Hepatol 67:526–534CrossRef Lee S, Kim SH, Lee JE, Sinn DH, Park CK (2017) Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma. J Hepatol 67:526–534CrossRef
11.
go back to reference Wu J, Liu A, Cui J, Chen A, Song Q, Xie L (2019) Radiomics-based classification of hepatocellular carcinoma and hepatic haemangioma on precontrast magnetic resonance images. BMC Med Imaging 19:23CrossRef Wu J, Liu A, Cui J, Chen A, Song Q, Xie L (2019) Radiomics-based classification of hepatocellular carcinoma and hepatic haemangioma on precontrast magnetic resonance images. BMC Med Imaging 19:23CrossRef
12.
go back to reference Shan QY, Hu HT, Feng ST et al (2019) CT-based peritumoral radiomics signatures to predict early recurrence in hepatocellular carcinoma after curative tumor resection or ablation. Cancer Imaging 19:11CrossRef Shan QY, Hu HT, Feng ST et al (2019) CT-based peritumoral radiomics signatures to predict early recurrence in hepatocellular carcinoma after curative tumor resection or ablation. Cancer Imaging 19:11CrossRef
13.
go back to reference Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278:563–577CrossRef Gillies RJ, Kinahan PE, Hricak H (2016) Radiomics: images are more than pictures, they are data. Radiology 278:563–577CrossRef
14.
go back to reference Dou TH, Coroller TP, van Griethuysen JJM, Mak RH, Aerts HJWL (2018) Peritumoral radiomics features predict distant metastasis in locally advanced NSCLC. PLoS One 13:e0206108CrossRef Dou TH, Coroller TP, van Griethuysen JJM, Mak RH, Aerts HJWL (2018) Peritumoral radiomics features predict distant metastasis in locally advanced NSCLC. PLoS One 13:e0206108CrossRef
15.
go back to reference Feng ST, Jia Y, Liao B et al (2019) Preoperative prediction of microvascular invasion in hepatocellular cancer: a radiomics model using Gd-EOB-DTPA-enhanced MRI. Eur Radiol 29:4648–4659CrossRef Feng ST, Jia Y, Liao B et al (2019) Preoperative prediction of microvascular invasion in hepatocellular cancer: a radiomics model using Gd-EOB-DTPA-enhanced MRI. Eur Radiol 29:4648–4659CrossRef
16.
go back to reference Roayaie S, Blume IN, Thung SN et al (2009) A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology 137:850–855CrossRef Roayaie S, Blume IN, Thung SN et al (2009) A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology 137:850–855CrossRef
17.
go back to reference Kim S, Shin J, Kim DY, Choi GH, Kim MJ, Choi JY (2019) Radiomics on gadoxetic acid-enhanced magnetic resonance imaging for prediction of postoperative early and late recurrence of single hepatocellular carcinoma. Clin Cancer Res 25:3847–3855CrossRef Kim S, Shin J, Kim DY, Choi GH, Kim MJ, Choi JY (2019) Radiomics on gadoxetic acid-enhanced magnetic resonance imaging for prediction of postoperative early and late recurrence of single hepatocellular carcinoma. Clin Cancer Res 25:3847–3855CrossRef
Metadata
Title
Gd-EOB-DTPA-enhanced MRI radiomics to predict vessels encapsulating tumor clusters (VETC) and patient prognosis in hepatocellular carcinoma
Authors
Yixing Yu
Yanfen Fan
Ximing Wang
Mo Zhu
Mengjie Hu
Cen Shi
Chunhong Hu
Publication date
01-02-2022
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 2/2022
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-021-08250-9

Other articles of this Issue 2/2022

European Radiology 2/2022 Go to the issue